ARCHIVES

Abraxane and Gemcitabine Improves Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Isis 3521 Gets Fast-track Status For FDA Review.

December 1, 2000

In Brief: Lepovetsky Heads New NCI Office Of Technology Development; Temporary Now, Maybe Permanent

November 27, 1987

Three CBCCPs Say They’ll Appeal To NC On Termination

March 21, 1980

In Brief: Barbara Britt Assumes ONS Presidency, O’Conner Is President-Elect; Kalt Joins NCI

May 25, 1990

DCBD Board Okays Concept Of Program Announcement To Stimulate Human Monoclonal Antibody Research

June 4, 1982

FDA Committee IK IL-2/LAK For Modified Group C

May 1, 1987